Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD74 is a non-coding RNA, part of the snoRNA class, specifically involved in the processing and chemical modification of other RNA molecules, most frequently guiding 2'-O-methylation of ribosomal RNAs[7]. SNORD74 is not classified as a protein-coding gene and is not considered a classical therapeutic target, such as a receptor, enzyme, or transporter[7]. There is no evidence for interacting drugs or biomarker applications, nor for significant safety concerns specific to this RNA. The primary biological role of SNORD74 is in the assembly and modification of ribosomes, primarily as a guide for the methylation of specific nucleotides in rRNA, aiding in ribosome biogenesis and RNA stability. Its molecular classification places it within the snoRNA family of non-coding RNAs. There is no notable connection to human disease, drug mechanisms, or safety concerns per current databases[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD74 (SNORD74).